Marc M. Greenberg
Johns Hopkins University · Biochemistry and Molecular Biology
Active 1974–2026
Academic metrics are sourced from OpenAlex and public funding records; values may differ from Google Scholar.
About
Marc Greenberg is the Vernon K. Krieble Professor of Chemistry at Johns Hopkins University, where he has been a faculty member since 2002. His research group focuses on organic and bioorganic chemistry, chemical biology, with particular emphasis on nucleic acids. Greenberg's work involves using organic chemistry, biochemistry, and molecular biology to understand and exploit the reactivity and structure of nucleic acids, aiming to address fundamental questions about nucleic acid chemistry and develop practical tools for biotechnology. He received his Ph.D. at Yale University under Professor Jerome Berson and trained as an American Cancer Society Postdoctoral Fellow at Caltech in Professor Peter Dervan's laboratory. Greenberg holds undergraduate degrees in Chemistry from New York University and in Chemical Engineering from the Cooper Union School of Engineering. He is a Fellow of the American Association for the Advancement of Science and has received several awards, including the Arthur C. Cope Scholar Award from the American Chemical Society in 2016 and an Alfred P. Sloan Foundation fellowship from 1996 to 2000. His research explores the chemical biology of nucleic acids, including understanding how cytotoxic antitumor agents target DNA, and developing tools for biotechnology. His group synthesizes novel molecules and studies their behavior using various physicochemical, biochemical, and biological techniques. Greenberg has also served as the Founding Director of the…
Research topics
- Chemistry
- Biochemistry
- Stereochemistry
- Molecular biology
- Photochemistry
Selected publications
Identifying Poly(ADP-ribose)-Binding Proteins with Photoaffinity-Based Proteomics
Journal of the American Chemical Society · 2021-02-17 · 73 citations
articleOpen accessCorrespondingPost-translational modification of proteins with poly(ADP-ribose) (PAR) is an important component of the DNA damage response. Four PAR synthesis inhibitors have recently been approved for the treatment of breast, ovarian, and prostate cancers. Despite the clinical significance of PAR, a molecular understanding of its function, including its binding partners, remains incomplete. In this work, we synthesized a PAR photoaffinity probe that captures and isolates endogenous PAR binders. Our method id…
Proceedings of the National Academy of Sciences · 2020-05-19 · 22 citations
articleOpen accessSignificance Small ribozymes are widespread in nature and have been engineered for artificial gene control in biotechnology and therapeutic applications. To understand how these simple RNA motifs work, we designed and synthesized a chemically protected “photocaged” nucleotide that blocks ribozyme folding until the block is removed with a short (≤0.03 s) pulse with a blue laser. We combined this tool with a microscope capable of observing single RNA molecules and showed that photocaged ribozymes…
Selective Inhibition of DNA Polymerase β by a Covalent Inhibitor
Journal of the American Chemical Society · 2021-05-20 · 17 citations
articleOpen accessSenior authorCorrespondingDNA polymerase β (Pol β) plays a vital role in DNA repair and has been closely linked to cancer. Selective inhibitors of this enzyme are lacking. Inspired by DNA lesions produced by antitumor agents that inactivate Pol β, we have undertaken the development of covalent small-molecule inhibitors of this enzyme. Using a two-stage process involving chemically synthesized libraries, we identified a potent irreversible inhibitor (14) of Pol β (KI = 1.8 ± 0.45 μM, kinact = (7.0 ± 1.0) × 10–3 s–1). Inhi…
Deoxyguanosine-Linked Bifunctional Inhibitor of SAMHD1 dNTPase Activity and Nucleic Acid Binding
ACS Chemical Biology · 2023-05-26 · 10 citations
articleOpen accessCorrespondingcomplex indicates that the biphenyl fragment impedes a conformational change in the C-terminal lobe that is required for tetramerization.
Chemical Research in Toxicology · 2023-04-24 · 10 citations
articleOpen accesstumor suppressor gene, was replicated in HEK 293T cells. 8-OxodGuo was only a weak block of replication, and the bypass was largely error-free. The mutations (1-5%) were primarily G → T transversions, and the mutation frequency was generally lower than that of the chemically related Fapy·dG. A unique 8-OxodGuo mutation spectrum was observed at each site, as reflected by replication in translesion synthesis (TLS) polymerase- or hPol λ-deficient cells. In codon 248 (CG*G) and 249 (AG*G), where G*…
Recent grants
NIH · $5.4M · 2020
NIH · $1.7M · 2008
NIH · $1.7M · 2024
Frequent coauthors
- 31 shared
Kelly M. Kroeger
Agilent Technologies (United States)
- 27 shared
Brian C. Bales
GE Global Research (United States)
- 25 shared
Carissa J. Wiederholt
Johns Hopkins University
- 22 shared
Michael O. Delaney
Cornell University
- 21 shared
Myron F. Goodman
University of Southern California
- 20 shared
Murat Saparbaev
Institut Gustave Roussy
- 20 shared
Jacques Laval
Université Paris-Saclay
- 20 shared
Jaeseung Kim
Qurient (South Korea)
Labs
Marc GreenbergPI
Awards & honors
- Arthur C. Cope Scholar Award from the American Chemical Soci…
- Fellow of the American Association for the Advancement of Sc…
- Alfred P. Sloan Foundation fellow (1996-2000)
- Founding Director of the Chemistry-Biology Interface program…
Similar researchers at Johns Hopkins University
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Marc M. Greenberg
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup
